Manufacturer record
Swiss Garnier Life Sciences: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
21 batches manufactured by Swiss Garnier Life Sciences (Himachal Pradesh) were declared Not of Standard Quality between August 2023 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 493TTF002, Telmisartan Tablets IP 40mg (exp Jun 2027). RDTL, Ernakulam (state lab) found it not of standard quality: The Sample does not conform to IP standards with respect to the test Dissolution. Listed in the September 2026 alert.
Records by type
21 records linked to Swiss Garnier Life Sciences in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Telmisartan Tablets IP 40mg | Batch 493TTF002Mfg Jul 2025 · Exp Jun 2027 | The Sample does not conform to IP standards with respect to the test Dissolution.Dissolution | RDTL , ErnakulamState lab | Sep 2026 |
| Albendazole Tablets IP 400mg) | Batch 418TAT001Mfg Apr 2025 · Exp Mar 2028 | content- AlbendazoleOther | Drug Testing Laboratory, Chennai-6State lab | Sep 2026 |
| Telmisartan Tablets IP 40 mg | Batch 493TTF024Mfg Aug 2025 · Exp Jul 2027 | The sample does not conform to IP standards with respect to the test DissolutionDissolution | RDTL, EKMState lab | Aug 2026 |
| Telmisartan Tablets IP 40 mg | Batch 493TTF026Mfg Nov 2025 · Exp Oct 2027 | The sample does not conform to IP standards with respect to the test Dissolution.Dissolution | RDTL, EKMState lab | Aug 2026 |
| Liquid Paraffin, Milk of Magnesia and sodium Picosulfate Oral Emulsion | Batch 85LLX015Mfg Jun 2025 · Exp May 2027 | General requirementsOther | DTL, Chennai-06State lab | Aug 2026 |
| Telmisartan Tablets IP 40 mg | Batch 493TTF004Mfg Jul 2025 · Exp Jun 2027 | The sample does not conform to IP standards. If fails the test Dissolution as per IPDissolution | DTL, TVPMState lab | Jul 2026 |
| Telmisartan Tablets IP 40 mg | Batch 493TTF014Mfg Aug 2025 · Exp Jul 2027 | The sample does not conform to IP standards. It fails the test Dissolution as per IPDissolution | DTL, TVPMState lab | Jul 2026 |
| Telmisartan Tablets IP 40 mg | Batch 493TTF009Mfg Aug 2025 · Exp Jul 2027 | The sample does not conform to IP standards with respect to the test Dissolution.Dissolution | RDTL, ErnakulamState lab | Jun 2026 |
| Gliclazide & Metformin hydrochloride sustained release tablets | Batch 475TGC002Mfg Jan 2026 · Exp Dec 2027 | ContentOther | DTL, Madurai-19State lab | May 2026 |
| Telmisartan Tablets IP 40mg | Batch 493TTF011Mfg Aug 2025 · Exp Jul 2027 | Dissolution as per IPDissolution | DTL, KonniState lab | Mar 2026 |
| Telmisartan Tablets IP 40mg | Batch 493TTF019Mfg Aug 2025 · Exp Jul 2027 | The sample fails the test 'Dissolution' as per IPDissolution | DTL ThrissurState lab | Mar 2026 |
| Telmisartan Tablets IP 40mg | Batch 493TTF022Mfg Aug 2025 · Exp Jul 2027 | Sample fails the test Dissolution as per IP, specified in the Laboratory ProtocolDissolution | DTL ThiruvananthapuramState lab | Feb 2026 |
| Telmisartan Tablets IP 40mg | Batch 493TTF015Mfg Aug 2025 · Exp Jul 2027 | Sample fails the test Dissolution as per IP, as specified in the Laboratory ProtocolDissolution | DTL ThiruvananthapuramState lab | Feb 2026 |
| Telmisartan Tablets IP 40mg | Batch 493TTF012Mfg Aug 2025 · Exp Jul 2027 | Sample fails the test Dissolution mentioned in the Laboratory Protocol as per IP.Dissolution | DTL KonniState lab | Feb 2026 |
| Telmisartan Tablets IP 40MG | Batch 493TTF008Mfg Jul 2025 · Exp Jun 2027 | Sample fails the test Dissolution as per IP, as specified in the Laboratory ProtocolDissolution | DTL ThiruvananthapuramState lab | Feb 2026 |
| Metformin Hydrochloride (ER) and Glimepiride Tablets IP | Batch 244TGT008Mfg Jun 2025 · Exp May 2027 | Assay for GlimepirideAssay | RDTL, Bellary, KarnatakaState lab | Jan 2026 |
| Telmisartan Tablets IP 40mg | Batch 493TTF020Mfg Aug 2025 · Exp Jul 2027 | Sample fails the test Dissolution.Dissolution | RDTL Ernakulam,KeralaState lab | Dec 2025 |
| Telmisartan Tablets IP 40mg | Batch 251TTF025Mfg Dec 2024 · Exp Nov 2027 | DissolutionDissolution | RDTL, GuwahatiCDSCO lab | May 2025 |
| Telmisartan Tablets IP 40 mg | Batch 251TTF036Mfg Dec 2024 · Exp Nov 2026 | DissolutionDissolution | RDTL, GuwahatiCDSCO lab | May 2025 |
| Telmisartan Tablets IP 40mg | Batch 251TTF014Mfg Aug 2024 · Exp Jul 2026 | DissolutionDissolution | RDTL, GuwahatiCDSCO lab | Mar 2025 |
| Aspirin Gastro-resistant and Atorvastatin Capsules IP (75mg/10mg) | Batch 54CAT09, 6Mfg Sep 2022 · Exp Aug 2024 | Dissolution (buffer stage) of Aspirin and The Assay of Atrovastatin Calcium calculated as AtorvastatinAssay | RDTL ChandigarhCDSCO lab | Aug 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.